Inventor
VAN OEVEREN CORNELIS ARJAN
US14 patents
⚠️ This page may combine multiple inventors who share the name “VAN OEVEREN CORNELIS ARJAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIGAND PHARM INC
11 patentsUS6566372B1May 20, 2003
Bicyclic androgen and progesterone receptor modulator compounds and methods
LIGAND PHARM INC103 citations95
US7727980B2Jun 1, 2010
Tricyclic androgen receptor modulator compounds and methods
LIGAND PHARM INC22 citations92
US7696246B2Apr 13, 2010
Bicyclic androgen and progesterone receptor modulator compounds and methods
LIGAND PHARM INC22 citations92
US7084151B2Aug 1, 2006
5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno[3,4-ƒ]quinolines as selective progesterone receptor modulator compounds
LIGAND PHARM INC22 citations92
US7071205B2Jul 4, 2006
5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
LIGAND PHARM INC26 citations92
US8865918B2Oct 21, 2014
Androgen receptor modulator compounds and methods
LIGAND PHARM INC15 citations91
US7026484B2Apr 11, 2006
Tricyclic androgen receptor modulator compounds and methods
LIGAND PHARM INC21 citations91
US11413274B2Aug 16, 2022
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
LIGAND PHARM INC0 citations59
US9359285B2Jun 7, 2016
Androgen receptor modulator compounds and methods
LIGAND PHARM INC1 citations50
US10736875B2Aug 11, 2020
Methods and compositions associated with the granulocyte colony-stimulating factor receptor
LIGAND PHARM INC0 citations48
US7163946B2Jan 16, 2007
5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
LIGAND PHARM INC0 citations41